NYU Cancer Institute at New York University Medical Center — New York, New York

NYU Cancer Institute at New York University Medical Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

NYU Cancer Institute at New York University Medical Center has participated in 60 clinical trials with 1 currently active.

Therapeutic areas: Anal Cancer, Colorectal Cancer, Metastatic Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, NSABP Foundation Inc, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Cancer Institute at New York University Medical Center?

NYU Cancer Institute at New York University Medical Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Cancer Institute at New York University Medical Center conducted?

NYU Cancer Institute at New York University Medical Center has 60 clinical trials on record, with 1 currently active. Their work covers Anal Cancer, Colorectal Cancer, Metastatic Cancer.

Is NYU Cancer Institute at New York University Medical Center accredited by Crixeo Health?

Yes — NYU Cancer Institute at New York University Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NYU Cancer Institute at New York University Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.